Lan Qing Han
Amministratore Delegato presso Cyagen Suzhou Biosciences Technology Co., Ltd.
Posizioni attive di Lan Qing Han
Società | Posizione | Inizio | Fine |
---|---|---|---|
Cyagen Suzhou Biosciences Technology Co., Ltd.
Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Amministratore Delegato | - | - |
Presidente | - | - |
Storia della carriera di Lan Qing Han
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Cyagen Suzhou Biosciences Technology Co., Ltd.
Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Health Technology |
- Borsa valori
- Insiders
- Lan Qing Han
- Esperienza